Cancer Archive — Page 25 of 67
-
October 28, 2021
VICC’s Mayer departing to take new role with AstraZeneca
Ingrid Mayer, MD, MSCI, is departing Vanderbilt University Medical Center for a new role as an executive with AstraZeneca. -
October 21, 2021
New robot enhances accuracy of head, neck cancer surgeries
-
October 21, 2021
Study to evaluate how environment impacts cancer risk
Vanderbilt-Ingram Cancer Center is leading an ambitious project to assess the impact of environmental exposures on cancer risk for people living in Southern states. -
October 19, 2021
Combo therapy slows prostate cancer
A new combination treatment showed promise in slowing the growth of castration-resistant prostate cancer in animal models, Vanderbilt researchers discovered. -
October 14, 2021
New marker for metaplasia
A protein that transports water, called aquaporin 5, is expressed by cells undergoing changes that may increase risk for gastric cancer development, Vanderbilt researchers discovered. -
October 14, 2021
Photoimmunotherapy offered in clinical trial for recurrent head and neck cancer
Vanderbilt-Ingram Cancer Center is recruiting patients for a clinical trial using photoimmunotherapy for recurrent head and neck cancer. -
September 30, 2021
Study shows how a protein coding gene confers breast cancer susceptibility during DNA transcription
Vanderbilt-Ingram Cancer Center research is providing new insights into how genetic variants convey breast cancer susceptibility by altering the transcription factor proteins that convert DNA strands into RNA.